Among other changes, the regulation proposed to remove three classes of drugs from a special protected list that guarantees seniors access to a wide selection of critical medications.
The three classes of drugs facing removal were antidepressants, antipsychotics and drugs that suppress the immune system to prevent rejection of a transplanted organ.
The administration hoped to save a total of $729 million by 2019 with the change. But patient groups including the National Kidney Foundation and the National Alliance on Mental Illness pushed back hard.
Medicare administrator Marilyn Tavenner said Monday in a letter to Congress that the administration will not move forward with the changes.
More Nation & World Headlines
Debris linked to missing Malaysian 777 6:39 p.m. 777 departs Aleutians after emergency landing 4:38 p.m. Export-Import Bank excluded from highway bill 6:56 p.m. Taliban leader Mullah Omar dead, Afghans say Administration wants to give prisoners access to Pell grants Health care spending to accelerate, US report says GOP leaders plan Senate vote on Planned Parenthood fed aid 8 children hurt, 2 critical, by falling tree in California
Our new comment system is not supported in IE 7. Please upgrade your browser here.